December 18, 2020
China's COVID-19 vaccine development has entered the "final sprint," with the country preparing for the mass production of COVID-19 vaccines, according to an official from the National Health Commission (NHC).
China has adopted five technological approaches in developing COVID-19 vaccines, with 15 vaccines entering clinical trials, of which five are undergoing phase-3 clinical trials.
Nearly two million doses of Chinese COVID-19 vaccines are on their way to Brazil. This is the second batch of Sinovac's COVID-19 vaccines to be delivered there.
In addition, Turkey has recently begun administering a Chinese COVID-19 vaccine candidate to non-medical volunteers as part of phase-3 clinical trial.
(Sources: The China Report)
Đăng nhận xét